Summer kick-off vibes from the #FärkkiläLab: we celebrated the start of the season (and our *brand new t-shirts👕*) with a BBQ party full of good food, laughs, and reflections. Looking back at a productive first half of the year and feeling motivated for what’s next. Let’s go🚀!

We’ve been a bit quiet from this account, but that’s about to change! Thrilled to share a huge milestone: our first PhD student, @fer-perezv.bsky.social, defended and graduated🎓! We’re sad to see him go, but so proud as he starts a postdoc at @harvardmed.bsky.social Congrats, Fer💙! #ProudLabMoment

Anniina Färkkilä@afarkkila.bsky.social · last yr.

Was a great honour to host Iain McNeish on World Ovarian Cancer Day! And huge congratulations to my student Fernando Perez-Villatoro for successfully defending his PhD #wocd #proudsupervisor @farkkilab.bsky.social @helsinki.fi

@afarkkila.bsky.social, Sara, Ada, and Aleksandra are representing the lab at ESSB in Berlin! Find them to discuss spatial biology! 🟠 Poster #88: Ada presents a spatial study of the cell cycle in #HGSC 🟠 Poster #155: Aleksandra showcases the use of ML to uncover spatial tumor ecosystems

📢Last chance! Final day to apply for our post-doc position! 🔬Join @afarkkila.bsky.social & the team in advancing #CancerResearch w/clinical impact in a collaborative and supportive environment. 📄Details here: farkkilab.org/careers/job-ads ⏳Apply today and/or help us spread the word by sharing!

1/n New paper alert 🚨 We're thrilled to share our just published paper in #CancerCell Do you ever wonder how the #TME in #HGSC changes during chemotherapy? Check it here: www.sciencedirect.com/science/arti... and let’s dive into the highlights together #spatialbiology #ovariancancer #cancerresarch

Chemotherapy induces myeloid-driven spatially confined T cell exhaustion in ovarian cancer

Anti-tumor immunity is crucial for high-grade serous ovarian cancer (HGSC) prognosis, yet its adaptation upon standard chemotherapy remains poorly und…

sciencedirect.com

A thread on our findings is coming later today—stay tuned! 📢

Anniina Färkkilä@afarkkila.bsky.social · 2y ago

Really happy to share our new publication! @anna-vaharautio.bsky.social Stay tuned for more insights! @farkkilab.bsky.social www.helsinki.fi/en/news/canc...

New preprint from our team is live🚨! Don’t miss it—read the preprint and send your thoughts our way: www.biorxiv.org/content/10.1... Congrats to Fernando and all the co-authors for the hard work 👏 #SpatialBiology #CancerResearch #OvarianCancer

Anniina Färkkilä@afarkkila.bsky.social · 2y ago

New preprint alert ‼️ @farkkilab.bsky.social We generated a single-cell spatial atlas of 280 metastatic #ovariancancer and found tumor MHCII as a key driver of tumor ecosystems and clinical outcomes. www.biorxiv.org/content/10.1...

New paper published! We modelled PARPi maintenance therapy in #ovariancancer www.nature.com/articles/s41...

Mathematical modeling framework enhances clinical trial design for maintenance treatment in oncology - Scientific Reports

Scientific Reports - Mathematical modeling framework enhances clinical trial design for maintenance treatment in oncology

nature.com

Matilda presenting her PhD work at NSGO Annual meeting 🎉💪🏼 #ovariancancer #clinicalcancerresrarch @farkkilab.bsky.social

We are looking for a postdoc (Please share 🙏)! Are you passionate about spatial biology, proteomics, and the TME? Join our culturally diverse, multidisciplinary, and friendly team in 🇫🇮 to make impactful discoveries in ovarian cancer 🧬Details: farkkilab.org/careers/job-... 📅Apply by Dec 11

Hi there👋! We’re the Systems Medicine of Tumor Microenvironment Lab. Our passion? Exploring the #TME through #SystemsOncology. Harnessing the power of our diverse and multidisciplinary team, we use innovative approaches to uncover #Biomarkers and transform these insights into clinical applications.